Oral status of patients submitted to autologous hematopoietic stem cell transplantation

被引:20
作者
Duval Fernandes, Liana Leite [1 ,2 ]
Torres, Sandra R. [3 ,4 ]
Garnica, Marcia [5 ]
Goncalves, Lucio de Souza [4 ]
Silva Junior, Arley [3 ,4 ]
de Vasconcellos, Alvaro Copello [5 ]
Cavalcanti, Wellington [6 ]
Maiolino, Angelo [5 ]
Medeiros de Barros Torres, Maria Cynesia [7 ]
机构
[1] Univ Fed Rio de Janeiro, BR-21941913 Rio De Janeiro, Brazil
[2] Jesuino Arruda, BR-04532080 Sao Paulo, Brazil
[3] Univ Fed Rio de Janeiro, Sch Dent, Dept Oral Pathol & Diag, BR-21941590 Rio De Janeiro, Brazil
[4] Univ Fed Rio de Janeiro, Clementino Fraga Filho Hosp, Oral Hlth Program, BR-21941913 Rio De Janeiro, RJ, Brazil
[5] Univ Fed Rio de Janeiro, Hosp Univ Clementino Fraga Filho, Hematol Serv, BR-21941913 Rio De Janeiro, Brazil
[6] Inst Hematol Arthur Siqueira Cavalcanti HEMORIO, Dept Dent, BR-20211030 Rio De Janeiro, Brazil
[7] Univ Fed Rio de Janeiro, Sch Dent, Dept Dent Clin, BR-21941590 Rio De Janeiro, Brazil
关键词
Hematopoietic stem cell transplantation; Periodontal diseases; Oral mucositis; Gingivitis; Bacteremia; BONE-MARROW-TRANSPLANTATION; CLINICAL-PRACTICE GUIDELINES; HIGH-DOSE CHEMOTHERAPY; INFECTIOUS COMPLICATIONS; MULTIPLE-MYELOMA; ACUTE-LEUKEMIA; DENTAL-CARE; CANCER; MUCOSITIS; BLOOD;
D O I
10.1007/s00520-013-1940-2
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Oral infection may be a source of bacteremia in patients undergoing hematopoietic stem cell transplant (HSCT). The aim of this study was to evaluate the relationship between patients with poor periodontal status and complications after HSCT. A cohort of patients with hematological malignancies candidates for autologous HSCT was observed before and during the neutropenic phase of HSCT. A primary evaluation was performed before the HSCT procedure, including medical and socio-demographic data and physical examination (number of teeth and decayed, missing and filled teeth index (DMFT), oral mucosa, and full mouth periodontal assessment). During the neutropenic phase, data regarding the development of febrile neutropenia, bacteremia, and mucositis were also prospectively obtained. Forty-eight patients were included. The most common baseline disease was multiple myeloma (70 %). In the primary evaluations, the median DMFT was 13 (ranging 0-27), and periodontitis and gingivitis were present in 29 and 60 % of the patients, respectively. During the neutropenic phase of HSCT, fever occurred in 96 % of patients, and bacteremia was documented in 29 %. Coagulase-negative Staphylococcus was the most common isolated bacteria. Patients who developed bacteremia had a higher frequency of oral disorders compared with those without bacteremia, but it was not statistically significant. Oral mucositis affected 89.6 % of the patients, and patients with gingivitis or periodontal disorders had a high frequency of mucositis. The prevalence of oral pathologic conditions previous to HSCT procedures was very high in the studied population. A possible association was noted between previous gingivitis and the development of mucositis during the neutropenia of HSCT.
引用
收藏
页码:15 / 21
页数:7
相关论文
共 45 条
  • [1] A retrospective investigation of advanced periodontal disease as a risk factor for septicemia in hematopoietic stem cell and bone marrow transplant recipients
    Akintoye, SO
    Brennan, MT
    Graber, CJ
    McKinney, BE
    Rams, TE
    Barrett, AJ
    Atkinson, JC
    [J]. ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY AND ENDODONTOLOGY, 2002, 94 (05): : 581 - 588
  • [2] Infectious complications after autologous hematopoietic stem cell transplantation: comparison of patients with acute myeloid leukemia, malignant lymphoma, and multiple myeloma
    Auner, HW
    Sill, H
    Mulabecirovic, A
    Linkesch, W
    Krause, R
    [J]. ANNALS OF HEMATOLOGY, 2002, 81 (07) : 374 - 377
  • [3] Cancer therapeutics: an update on its effects on oral health
    Barasch, Andrei
    Coke, John M.
    [J]. PERIODONTOLOGY 2000, 2007, 44 : 44 - 54
  • [4] Current practices in the oral management of the patient undergoing chemotherapy or bone marrow transplantation
    Barker, GJ
    [J]. SUPPORTIVE CARE IN CANCER, 1999, 7 (01) : 17 - 20
  • [5] Changing paradigms in the treatment of multiple myeloma
    Blade, Joan
    Rosinol, Laura
    [J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 (02): : 163 - 166
  • [6] Borowski B, 1994, Eur J Cancer B Oral Oncol, V30B, P93, DOI 10.1016/0964-1955(94)90059-0
  • [7] Levofloxacin to prevent bacterial infection in patients with cancer and neutropenia
    Bucaneve, G
    Micozzi, A
    Menichetti, F
    Martino, P
    Dionisi, MS
    Martinelli, G
    Allione, B
    D'Antonio, D
    Buelli, M
    Nosari, AM
    Cilloni, D
    Zuffa, E
    Cantaffa, R
    Specchia, G
    Amadori, S
    Fabbiano, F
    Deliliers, GL
    Lauria, F
    Foà, R
    Del Favero, A
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (10) : 977 - 987
  • [8] No association between cigarette smoking and incidence of plasma cell myeloma: A meta-analysis of 17 observational studies
    Castillo, Jorge J.
    Dhami, Pradeep K.
    Curry, Stephanie
    Brennan, Keith
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 2012, 87 (07) : 729 - 731
  • [9] Rhizobium radiobacter as an opportunistic pathogen in central venous catheter-associated bloodstream infection:: case report and review
    Chen, C. -Y.
    Hansen, K. S.
    Hansen, L. K.
    [J]. JOURNAL OF HOSPITAL INFECTION, 2008, 68 (03) : 203 - 207
  • [10] Evolution, incidence, and susceptibility of bacterial bloodstream isolates from 519 bone marrow transplant patients
    Collin, BA
    Leather, HL
    Wingard, JR
    Ramphal, R
    [J]. CLINICAL INFECTIOUS DISEASES, 2001, 33 (07) : 947 - 953